SYNEURX

Welcome to the Brand page for “SYNEURX”, which is offered here for Pharmaceutical products and substances for treating neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders;pharmaceutical preparations and drug development services for developing drug treating neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders;.

Its status is currently believed to be active. Its class is unavailable. “SYNEURX” is believed to be currently owned by “Tsai, Guochuan E.”